Obtaining the certificate represents a recognition by the Global Food Safety Initiative (GFSI), indicating GeneFerm Biotechnology's complete and effective food safety management system (FSMS) has met GFSI's international food safety standards, and possess the ability to satisfy the requirements from authorities, food industry clients and consumers.
MoreGeneFerm Biotechnology's Nanke factory plant 2 will be starting mass production in 2023. In recent years, precision fermentation industry is booming worldwide along with the increasing demand of professional advice. GeneFerm will offer professional CDMO service based on our mass production technology and experience, achieving another peak on our sales performance.
MoreGeneFerm Biotechnology expanded Nanke factory plant with the new Plant 2, which was open in November, 2022. Equipped with two 66,000-liter/66-ton fermenter and related purification facilities, we are able to undertake increased order volume, as well as precision fermentation development and mass production of new products.
MoreCongratulations to GeneFerm Biotechnology for obtaining A.A. clean label certification for it's product "Ganoderma lucidum polysaccharides composite composition drink". Through third-party supervision mechanism and cleanliness enhancement as social responsibility, we strengthen our production standards, continue to develop healthy, sustainable and high-quality functional products with good flavor for all consumers.
Congratulations to GeneFerm Biotechnology for its「Golden Future Lutein Compound Liquid Capsule Bright Plus」及「"Golden Future Magic Reds Natto Monascus Capsule」for winning the gold and bronze medals in the 2022 Monde Selection® World Quality Evaluation Awards.
Congratulate GeneFerm Biotechnology for its dual-effect immune function of "Ganoderma lucidum polysaccharides composite composition" after obtaining the invention patent of Taiwan, and then obtaining the affirmation of the US invention patent. It can be affirmed by multi-national patents and has a clear health effect verification, which can provide you with the most competitive powerful functional raw materials.More
Congratulations to GeneFerm Biotechnology for its "Golden Future Lutein Compound Liquid Capsule Bright Plus" and "Golden Future Magic Reds Natto Monascus Capsule" for winning the gold and bronze medals in the 2022 Monde Selection® World Quality Evaluation Awards.
Congratulate GeneFerm Biotechnology for its dual-effect immune function of "Ganoderma lucidum polysaccharides composite composition" after obtaining the invention patent of Taiwan, and then obtaining the affirmation of the US invention patent. It can be affirmed by multi-national patents and has a clear health effect verification, which can provide you with the most competitive powerful functional raw materials.Detail
GeneFerm have participated in various charitable and public welfare activities, including but not limited to the donation of living supplies to underprivileged families, care for solitary elderly, vaccine purchase support, and assist education of students in rural areas. By November of 2021, the amount of donation have exceeded 20,000,000 NTs! We are always dedicated, and feel responsible in continuing the care for minorities, to keep love spread around the world.Detail
Congratulate GeneFerm Biotechnology for obtaining Utility Model Patent for [Mobilized Forced Convectional Basket Extractor] from Both Germany and Taiwan, providing greater variety of high yield extraction process choices for customers.Detail
GeneFerm's latest ingredient, β-glucan and mushroom polysaccharides complex, has been recognized by the Taiwan Invention Patent that can boost the activity of natural killer cells or the production of IgA or IgM antibodies.Detail
GeneFerm has been carrying out public welfare for a long time and continuously. From May to July, all walks of life were even more affected by the impact of the COVID-19 epidemic. We assisted poor children to implement suspension of classes and non-stop school, support the procurement of vaccines and epidemic prevention and relief projects; caring heart is an anti-epidemic force as well.
GeneFerm obtained China patent for “continuous production equipment for LaLaBling.”
GeneFerm is the leading company to obtain GMP Certificate (capsules, liquid, powder) in the industry.
GeneFerm Biotechnology works with World Vision Taiwan to assist disadvantaged teenagers in their education and career development. Detail
GeneFerm obtained three gold medals at 2020 Tokyo Genius Invention Exhibition and 2020 Korea WiC. Detail
GeneFerm obtained Japanese patent for technique of producing high-activity Nattokinase.
GeneFerm Taipei Business Office has moved to Taipei Nangang Software Park !
ADD: Nangang Software Park, Building F, 4F-3, No. 3, Park St., Nangang Dist., Taipei City 115603, Taiwan
TEL: +886-2-26558479 FAX:+886-2-26558476
GeneFerm the latestPostbiotics won the Silver Medal Award in The 33rd world Genius Convention & Education Expo 2019 in Tokyo.
GeneFerm Vitamin K2 product - NattoMena® has won the gold medal award in the International Innovation and Invention competition!
Vice President-Frank Hsiao is invited to Taiwan-Thailand Industrial Collaboration Summit for sharing successful cooperation with Thailand.
GeneFerm is certified with GMP certificate from NSF.
GeneFerm has been officially listed on TPEx since January 22nd, 2018. (Stock Code:1796)
GeneFerm (stock code:1796) successfully completed Performance Conference before TPEx-listed.
GeneFerm is awarded 2017 D&B TOP 1000 SMEs Elite Award!
New GMP-compliant Solid Preparation plant opening.
Functional lactic acid bacteria- Lactobacillus fermentum ,heat-killed lactic acid bacteria.
Bureau Veritas Certification: ISO9001 / ISO22000 / HACCP
Increase scale-up facilities and capacity: 2 sets of 55,000L fermentors, large scale freeze dryer, auto filter press and other equipments.
Antrodia cinnamomea extract liquor for reducing blood alcohol concentration (patent certificate No. 2301294)
Jiangsu GeneFerm Biotechnology is established as the third subsidiary of GeneFerm at China Medical City in Taizhou.
Approved by Taipei Exchange, GeneFerm (1796) has registered and listed in the emerging stock market.